{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T17:12:55Z","timestamp":1779297175027,"version":"3.51.4"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,27]]},"DOI":"10.7759\/cureus.74621","type":"journal-article","created":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:00:37Z","timestamp":1732766437000},"source":"Crossref","is-referenced-by-count":1,"title":["A Randomized Double-Blind Placebo-Controlled Study on the Safety and Efficacy of Probiotics for Insulin Resistance and Oxidative Stress Markers in Diabetic Patients With End-Stage Renal Disease on Hemodialysis"],"prefix":"10.7759","author":[{"given":"Usharani","family":"Pingali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja Karthik","family":"Kalidindi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Padmaja","family":"Mekala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Imran","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease-a systematic review and meta-analysis","volume":"11","author":"Hill NR","year":"2016","unstructured":"Hill NR, Fatoba ST, Oke JL, Hirst JA, O'Callaghan CA, Lasserson DS, Hobbs FD. Global prevalence of chronic kidney disease-a systematic review and meta-analysis. PLoS One. 2016, 11:e0158765. 10.1371\/journal.pone.0158765","journal-title":"PLoS One"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(20)30045-3","article-title":"Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"395","author":"GBD Chronic Kidney Disease Collaboration","year":"2020","unstructured":"GBD Chronic Kidney Disease Collaboration. Global, regional, and national burden of chronic kidney disease, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2020, 395:709-33. 10.1016\/S0140-6736(20)30045-3","journal-title":"Lancet"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.2215\/CJN.09180817","article-title":"Chronic kidney disease in India: a clarion call for change","volume":"13","author":"Varughese S","year":"2018","unstructured":"Varughese S, Abraham G. Chronic kidney disease in India: a clarion call for change. Clin J Am Soc Nephrol. 2018, 13:802-4. 10.2215\/CJN.09180817","journal-title":"Clin J Am Soc Nephrol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1159\/isbn.978-3-8055-8567-5","article-title":"Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease","volume":"161","author":"Siew ED","year":"2008","unstructured":"Siew ED, Ikizler TA. Determinants of insulin resistance and its effects on protein metabolism in patients with advanced chronic kidney disease. Contrib Nephrol. 2008, 161:138-44. 10.1159\/isbn.978-3-8055-8567-5","journal-title":"Contrib Nephrol"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1159\/000014381","article-title":"Imbalance of oxidants and antioxidants in haemodialysis patients","volume":"17","author":"Canaud B","year":"1999","unstructured":"Canaud B, Cristol J, Morena M, Leray-Moragues H, Bosc J, Vaussenat F. Imbalance of oxidants and antioxidants in haemodialysis patients. Blood Purif. 1999, 17:99-106. 10.1159\/000014381","journal-title":"Blood Purif"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4155\/fsoa-2019-0013","article-title":"Gut microbial metabolites as mediators of renal disease: do short-chain fatty acids offer some hope?","volume":"5","author":"Heaney LM","year":"2019","unstructured":"Heaney LM, Davies OG, Selby NM. Gut microbial metabolites as mediators of renal disease: do short-chain fatty acids offer some hope?. Future Sci OA. 2019, 5:FSO384. 10.4155\/fsoa-2019-0013","journal-title":"Future Sci OA"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110503","article-title":"Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment","volume":"130","author":"Yang F","year":"2020","unstructured":"Yang F, Chen H, Gao Y, et al.. Gut microbiota-derived short-chain fatty acids and hypertension: mechanism and treatment. Biomed Pharmacother. 2020, 130:110503. 10.1016\/j.biopha.2020.110503","journal-title":"Biomed Pharmacother"},{"key":"ref8","article-title":"Guidelines for the evaluation of probiotics in food: report of a Joint FAO\/WHO Working Group","author":"FAO\/WHO","year":"2002","unstructured":"FAO\/WHO. Guidelines for the evaluation of probiotics in food: report of a Joint FAO\/WHO Working Group. London, Ontario, Canada; 2002. https:\/\/isappscience.org\/wp-content\/uploads\/2019\/04\/probiotic_guidelines.pdf."},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph110504745","article-title":"Microorganisms with claimed probiotic properties: an overview of recent literature","volume":"11","author":"Fijan S","year":"2014","unstructured":"Fijan S. Microorganisms with claimed probiotic properties: an overview of recent literature. Int J Environ Res Public Health. 2014, 11:4745-67. 10.3390\/ijerph110504745","journal-title":"Int J Environ Res Public Health"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2146\/ajhp090168","article-title":"Probiotics","volume":"67","author":"Williams NT","year":"2010","unstructured":"Williams NT. Probiotics. Am J Health Syst Pharm. 2010, 67:449-58. 10.2146\/ajhp090168","journal-title":"Am J Health Syst Pharm"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1089\/bfm.2019.0301","article-title":"Can synbiotic dietary pattern predict Lactobacillales strains in breast milk?","volume":"15","author":"Bahreini-Esfahani N","year":"2020","unstructured":"Bahreini-Esfahani N, Moravejolahkami AR. Can synbiotic dietary pattern predict Lactobacillales strains in breast milk?. Breastfeed Med. 2020, 15:387-93. 10.1089\/bfm.2019.0301","journal-title":"Breastfeed Med"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1038\/ki.2015.255","article-title":"Probiotics and chronic kidney disease","volume":"88","author":"Koppe L","year":"2015","unstructured":"Koppe L, Mafra D, Fouque D. Probiotics and chronic kidney disease. Kidney Int. 2015, 88:958-66. 10.1038\/ki.2015.255","journal-title":"Kidney Int"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3390\/jcm12051948","article-title":"Gut microbiota in chronic kidney disease: from composition to modulation towards better outcomes-a systematic review","volume":"12","author":"Voroneanu L","year":"2023","unstructured":"Voroneanu L, Burlacu A, Brinza C, et al.. Gut microbiota in chronic kidney disease: from composition to modulation towards better outcomes-a systematic review. J Clin Med. 2023, 12:1948. 10.3390\/jcm12051948","journal-title":"J Clin Med"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0283389","article-title":"Changes in gut microbial community upon chronic kidney disease","volume":"18","author":"Liu W","year":"2023","unstructured":"Liu W, Huang J, Liu T, Hu Y, Shi K, Zhou Y, Zhang N. Changes in gut microbial community upon chronic kidney disease. PLoS One. 2023, 18:e0283389. 10.1371\/journal.pone.0283389","journal-title":"PLoS One"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.3390\/life12081187","article-title":"Probiotic mechanisms affecting glucose homeostasis: a scoping review","volume":"12","author":"Pintari\u010d M","year":"2022","unstructured":"Pintari\u010d M, Langerholc T. Probiotic mechanisms affecting glucose homeostasis: a scoping review. Life (Basel). 2022, 12:1187. 10.3390\/life12081187","journal-title":"Life (Basel)"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.85.12.7025","article-title":"Insulin sensitivity and its measurement: structural commonalities among the methods","volume":"85","author":"Radziuk J","year":"2000","unstructured":"Radziuk J. Insulin sensitivity and its measurement: structural commonalities among the methods. J Clin Endocrinol Metab. 2000, 85:4426-33. 10.1210\/jcem.85.12.7025","journal-title":"J Clin Endocrinol Metab"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1016\/j.kint.2016.09.040","article-title":"Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects","volume":"91","author":"Soleimani A","year":"2017","unstructured":"Soleimani A, Zarrati Mojarrad M, Bahmani F, et al.. Probiotic supplementation in diabetic hemodialysis patients has beneficial metabolic effects. Kidney Int. 2017, 91:435-42. 10.1016\/j.kint.2016.09.040","journal-title":"Kidney Int"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1186\/s13098-020-00603-6","article-title":"Probiotics supplementation and insulin resistance: a systematic review","volume":"12","author":"Salles BI","year":"2020","unstructured":"Salles BI, Cioffi D, Ferreira SR. Probiotics supplementation and insulin resistance: a systematic review. Diabetol Metab Syndr. 2020, 12:98. 10.1186\/s13098-020-00603-6","journal-title":"Diabetol Metab Syndr"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1007\/s12602-018-9499-3","article-title":"The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: a randomized, double-blinded, placebo-controlled trial","volume":"11","author":"Soleimani A","year":"2019","unstructured":"Soleimani A, Motamedzadeh A, Zarrati Mojarrad M, et al.. The effects of synbiotic supplementation on metabolic status in diabetic patients undergoing hemodialysis: a randomized, double-blinded, placebo-controlled trial. Probiotics Antimicrob Proteins. 2019, 11:1248-56. 10.1007\/s12602-018-9499-3","journal-title":"Probiotics Antimicrob Proteins"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1111\/hdi.12748","article-title":"A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients","volume":"23","author":"Kooshki A","year":"2019","unstructured":"Kooshki A, Tofighiyan T, Miri M. A synbiotic supplement for inflammation and oxidative stress and lipid abnormalities in hemodialysis patients. Hemodial Int. 2019, 23:254-60. 10.1111\/hdi.12748","journal-title":"Hemodial Int"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1017\/S0007114514000919","article-title":"Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study","volume":"112","author":"Eslamparast T","year":"2014","unstructured":"Eslamparast T, Zamani F, Hekmatdoost A, Sharafkhah M, Eghtesad S, Malekzadeh R, Poustchi H. Effects of synbiotic supplementation on insulin resistance in subjects with the metabolic syndrome: a randomised, double-blind, placebo-controlled pilot study. Br J Nutr. 2014, 112:438-45. 10.1017\/S0007114514000919","journal-title":"Br J Nutr"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1111\/dme.13528","article-title":"Incident ischaemic stroke and type 2 diabetes: trends in incidence and case fatality in Scotland 2004-2013","volume":"35","author":"Read SH","year":"2018","unstructured":"Read SH, McAllister DA, Colhoun HM, et al.. Incident ischaemic stroke and type 2 diabetes: trends in incidence and case fatality in Scotland 2004-2013. Diabet Med. 2018, 35:99-106. 10.1111\/dme.13528","journal-title":"Diabet Med"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/j.clnesp.2020.06.019","article-title":"Efficacy of probiotic supplementation in patients with diabetic nephropathy: a systematic review and meta-analysis","volume":"40","author":"AbdelQadir YH","year":"2020","unstructured":"AbdelQadir YH, Hamdallah A, Sibaey EA, et al.. Efficacy of probiotic supplementation in patients with diabetic nephropathy: a systematic review and meta-analysis. Clin Nutr ESPEN. 2020, 40:57-67. 10.1016\/j.clnesp.2020.06.019","journal-title":"Clin Nutr ESPEN"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1186\/s12967-020-02213-2","article-title":"Effects of probiotics on type II diabetes mellitus: a meta-analysis","volume":"18","author":"Tao YW","year":"2020","unstructured":"Tao YW, Gu YL, Mao XQ, Zhang L, Pei YF. Effects of probiotics on type II diabetes mellitus: a meta-analysis. J Transl Med. 2020, 18:30. 10.1186\/s12967-020-02213-2","journal-title":"J Transl Med"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/279848-a-randomized-double-blind-placebo-controlled-study-on-the-safety-and-efficacy-of-probiotics-for-insulin-resistance-and-oxidative-stress-markers-in-diabetic-patients-with-end-stage-renal-disease-on-hemodialysis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,28]],"date-time":"2024-11-28T04:00:39Z","timestamp":1732766439000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/279848-a-randomized-double-blind-placebo-controlled-study-on-the-safety-and-efficacy-of-probiotics-for-insulin-resistance-and-oxidative-stress-markers-in-diabetic-patients-with-end-stage-renal-disease-on-hemodialysis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,27]]},"references-count":24,"URL":"https:\/\/doi.org\/10.7759\/cureus.74621","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,27]]}}}